Cornercap Investment Counsel’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Cornercap Investment Counsel’s Portfolio JNCE Stock Details JNCE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$175K	Hold
2022 Q4	$105K	Hold
2022 Q3	$222K	Buy
2022 Q2	$127K	Buy